Table 4. Co-occurrence of functioning impairment and presence or absence of attenuated psychotic symptoms at follow-up by intervention group.

Functioning*	Presence or absence of attenuated psychotic symptoms
	All non-transitioned				Omega-3 group				Placebo group
	Present (N=11)		Absent (N=38)		Present (N=8)		Absent (N=22)		Present (N=3)		Absent (N=16)
	N	%	N	%	N	%	N	%	N	%	N	%
Good functioning	4	36.4	20	52.6	3	37.5	11	50.0	1	33.3	9	56.3
Mild or moderate impairment	6	54.5	15	39.5	4	50.0	10	45.5	2	66.7	5	31.3
Severe impairment	1	9.1	3	7.9	1	12.5	1	4.5	0	0.0	2	12.5

^*Good functioning GAF score >70; mild or moderate impairment GAF score between 51 and 70; severe impairment GAF score ≤50.